With the analysis among 521 patents, we discovered top 140 key players by total patent application. Novartis AG, Abbott Cardiovascular Systems, Inc., Eisai R&D Management Co., Ltd. are dominant in this area. They take 30.52% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 81
Abbott Cardiovascular Systems, Inc.
California, United States
Patent: 40
Eisai R&D Management Co., Ltd.
Tokyo-to, Japan
Patent: 38
Cambridgeshire, United Kingdom
Patent: 22
ARIAD Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 14
ZURICH, Switzerland
Patent: 13
Radius Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 13
Shandong New Times Pharmaceutical Co., Ltd.
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Karnataka, India
Patent: 9
With the analysis among 8 patents, we discovered top 4 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Immunogenesis, Inc., Urotronic, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Texas, United States
Patent: 1
Minnesota, United States
Patent: 1
With the analysis among related 180 patents applied in the last 5 years. We discover 65 most active companies in this area. The fast-growing GW Research Ltd., Osaka University, AstraZeneca Pharmaceutical Co., Ltd. take 24.44% of patent filing during this period.
Cambridgeshire, United Kingdom
Patent: 21
Osaka-fu, Japan
Patent: 12
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 8
Chong Kun Dang Pharmaceutical Corp.
Eisai R&D Management Co., Ltd.
Basel-Stadt, Switzerland
Patent: 4
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 4
University of Tennessee Research Foundation
Tennessee, United States
Patent: 4
Radius Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
With the analysis among related 180 patents in last 5 years, we discover 54 new entrants. Osaka University, AstraZeneca Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Co., Ltd. are the most active new entrants in this area.
Osaka-fu, Japan
Patent: 12
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 8
Chong Kun Dang Pharmaceutical Corp.
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 4
University of Tennessee Research Foundation
Tennessee, United States
Patent: 4
MedicalSystem Biotechnology Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Zhuohe Pharmaceutical Group Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Intas Pharmaceuticals Ltd.
Schwyz, Switzerland
Patent: 3
With the analysis among 51 patents, we discovered top 17 universities and scientific research institutions by total patent application. Osaka University, Emory University, Université Claude Bernard Lyon 1 are dominant in this area. They take 41.18% of the total patent filing.
Osaka-fu, Japan
Patent: 12
Georgia, United States
Patent: 4
Université Claude Bernard Lyon 1
University of Cincinnati Physicians Co. LLC
Ohio, United States
Patent: 3
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 3
Georgetown University School of Medicine
District of Columbia, United States
Patent: 2
North Carolina, United States
Patent: 1
Jilin Sheng, China
Patent: 1